dengue vaccine
Making Vaccines About Science, Not Politics
In the wake of political turmoil and widespread misinformation around Dengvaxia in the Philippines, public confidence in vaccines has plummeted sharply, says a new study. What can be done to hold back the slide?
Public Trust In Vaccines Plummets After Dengvaxia Controversy
Confidence in vaccine safety and efficacy have declined precipitously following the Dengvaxia scandal in 2017.
Mum’s Antibodies Interfere With Baby’s Dengue Response
Antibodies from mice vaccinated with one strain of dengue virus while pregnant have been found to worsen symptoms in their pups infected with other strains.
The Philippines Pauses Dengue Vaccine Program
New findings indicate that vaccination could lead to more severe disease in people who have never had a prior dengue infection.
Promising Clinical Results For Takeda’s Dengue Vaccine
Takeda’s dengue vaccine candidate TAK-003 has been shown to provide protection against all four serotypes of the virus for at least 18 months.
Beating Dengue Is In Your DNA (Vaccine)
A DNA-based vaccine against dengue, which would not require cold chain transport, has been shown to protect mice against two out of the four strains of dengue virus.
Promising Results For Takeda’s Dengue Vaccine
Takeda's dengue vaccine has proven to be safe and able to produce an antibody response against all four serotypes of dengue in an interim analysis of their ongoing Phase 2 trial.
What You Need To Know About Dengvaxia, Sanofi Pasteur’s Dengue Vaccine
Dr. Ng Su-Peing, global medical head of Sanofi Pasteur, explains how Dengvaxia can address the burden of dengue around the world.
Promising Dengue Vaccine Faces Final Test
The TV003 vaccine, which researchers believe will protect against all four strains of dengue, is set to complete a phase III trial by 2018.
A Shot In The Arm For Dengue Control?
The world's first dengue vaccine is good news, but not a perfect solution.
